Raiffeisen Bank International AG Has $669,000 Stock Position in STAAR Surgical Company $STAA

Raiffeisen Bank International AG lowered its stake in shares of STAAR Surgical Company (NASDAQ:STAA) by 50.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 40,000 shares of the medical instruments supplier’s stock after selling 40,000 shares during the quarter. Raiffeisen Bank International AG owned approximately 0.08% of STAAR Surgical worth $669,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. CWM LLC lifted its position in shares of STAAR Surgical by 74.1% during the second quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 665 shares in the last quarter. US Bancorp DE raised its position in STAAR Surgical by 1,693.0% in the 1st quarter. US Bancorp DE now owns 2,044 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 1,930 shares during the last quarter. Brooklyn Investment Group lifted its holdings in STAAR Surgical by 1,564.0% during the 1st quarter. Brooklyn Investment Group now owns 2,679 shares of the medical instruments supplier’s stock worth $47,000 after buying an additional 2,518 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in STAAR Surgical by 691.0% in the 2nd quarter. PNC Financial Services Group Inc. now owns 3,607 shares of the medical instruments supplier’s stock valued at $61,000 after buying an additional 3,151 shares during the last quarter. Finally, AlphaQuest LLC boosted its position in STAAR Surgical by 197.4% in the 2nd quarter. AlphaQuest LLC now owns 10,879 shares of the medical instruments supplier’s stock valued at $183,000 after buying an additional 7,221 shares during the last quarter. Institutional investors and hedge funds own 96.70% of the company’s stock.

STAAR Surgical Trading Down 3.1%

NASDAQ STAA opened at $25.67 on Wednesday. STAAR Surgical Company has a 12 month low of $13.50 and a 12 month high of $30.81. The stock has a 50-day simple moving average of $26.59 and a 200 day simple moving average of $22.73. The company has a market capitalization of $1.28 billion, a PE ratio of -13.30 and a beta of 0.92.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on STAA shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of STAAR Surgical in a research note on Wednesday, October 8th. Stifel Nicolaus set a $28.00 price objective on STAAR Surgical and gave the stock a “hold” rating in a report on Thursday, August 7th. Canaccord Genuity Group restated a “hold” rating and set a $28.00 target price on shares of STAAR Surgical in a research report on Tuesday, October 21st. Finally, Piper Sandler reaffirmed a “neutral” rating on shares of STAAR Surgical in a research note on Monday, October 27th. Ten equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus price target of $20.67.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.